Cargando…
MON-290 Ipilimumab Immune-Related ACTH Deficiency Is of Acute Onset and Severe
Introduction Immune checkpoint inhibitors (ICIs) are immunomodulatory molecules that downregulate T-cell inhibiting-receptors or ligands to promote an enhanced anti-tumour response. Ipilimumab is a human monoclonal antibody directed against cytotoxic T-lymphocyte antigen-4 (CTLA-4) that has been sho...
Autores principales: | Seejore, Khyatisha, Giannoudi, Marilena, Osborn, Djoah, Lynch, Julie Marie, Dunwoodie, Elaine, Hook, Jane, Marples, Maria, Murray, Robert Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208295/ http://dx.doi.org/10.1210/jendso/bvaa046.1486 |
Ejemplares similares
-
MON-302 The Prevalence of Acromegaly in the Sleep Apnoea Clinic
por: Lynch, Julie Marie, et al.
Publicado: (2020) -
SUN-414 Immune Related Adverse Events: Isolated ACTH Deficiency with Nivolumab/Ipilimumab Combination Therapy
por: Magdaleno, Angela, et al.
Publicado: (2019) -
MON-409 Ectopic ACTH Syndrome with a Pituitary Mass
por: Lake, Julia, et al.
Publicado: (2019) -
MON-405 Cushing's Disease: An Oligosymptomatic Patient with ACTH-Secreting Pituitary Macroadenoma
por: Manrique Franco, Katty, et al.
Publicado: (2019) -
MON-LB58 The Use of 11C Methionine PET CT In Localization of ACTH Dependent Cushing’s Disease
por: ElEbrashy, Shady Ibrahim, et al.
Publicado: (2020)